Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A (2004) 19.84

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42

Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology (2007) 12.42

Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci (2009) 12.05

Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86

Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50

Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA (2008) 7.35

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04

Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02

Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc (2007) 6.94

Canadian study of health and aging: study methods and prevalence of dementia. CMAJ (1994) 6.91

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 6.84

Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol (2010) 6.55

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29

Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A (1989) 5.97

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 5.89

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86

Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69

Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med (2016) 5.55

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ (1999) 5.36

Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med (2008) 5.34

Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput Biol (2008) 5.15

The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96

Glucose levels and risk of dementia. N Engl J Med (2013) 4.95

Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89

Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol (2004) 4.89

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85

Cancer linked to Alzheimer disease but not vascular dementia. Neurology (2009) 4.83

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology (2013) 4.80

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry (2006) 4.74

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol (2009) 4.71

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet (2008) 4.66

Hearing loss and incident dementia. Arch Neurol (2011) 4.65

The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59

Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med (2015) 4.57

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51

Influence of leisure activity on the incidence of Alzheimer's disease. Neurology (2001) 4.49

Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med (2009) 4.45

Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ (2009) 4.41

Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39

Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol (2011) 4.38

Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA (2010) 4.36

Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med (2012) 4.22

Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet (1991) 4.19

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16

Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol (2008) 4.14

Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A (2002) 4.07

Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA (2009) 4.02

Food combination and Alzheimer disease risk: a protective diet. Arch Neurol (2010) 3.99

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol (2008) 3.99

The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry (1999) 3.98

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97

Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry (2007) 3.92

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology (2005) 3.90

Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86

Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain (2010) 3.84

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ (2005) 3.83

Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke (2004) 3.80

Systemic inflammation and disease progression in Alzheimer disease. Neurology (2009) 3.79

Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke (2010) 3.75

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71

Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64

Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA (2009) 3.62

Hypertension and the risk of mild cognitive impairment. Arch Neurol (2007) 3.62

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology (2012) 3.58

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. JAMA Neurol (2015) 3.58

Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet (2009) 3.54

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53

A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology (2009) 3.49

Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry (2008) 3.48

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol (2012) 3.46

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. Lancet Neurol (2013) 3.46

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry (1983) 8.71

Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95

The private finance initiative: planning the "new" NHS: downsizing for the 21st century. BMJ (1999) 5.83

The private finance initiative. NHS capital expenditure and the private finance initiative-expansion or contraction? BMJ (1999) 5.31

Pathological verification of ischemic score in differentiation of dementias. Ann Neurol (1980) 5.25

P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev (1997) 5.13

Profiting from closure: the private finance initiative and the NHS. BMJ (1997) 4.43

The private finance initiative: PFI in the NHS--is there an economic case? BMJ (1999) 4.01

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79

Rewriting the regulations: how the World Trade Organisation could accelerate privatisation in health-care systems. Lancet (2000) 3.72

The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science (1987) 3.59

The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57

Fine structure and electrolyte analyses of cerebral edema induced by alkyl tin intoxication. J Neuropathol Exp Neurol (1963) 3.43

Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18

Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04

Slow persistent infection caused by visna virus: role of host restriction. Science (1977) 2.83

Head drop and camptocormia. J Neurol Neurosurg Psychiatry (2002) 2.78

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol (1976) 2.62

Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60

Life span and synapses: will there be a primary senile dementia? Neurobiol Aging (2001) 2.55

Doctors' unawareness of the drugs their patients are taking: a major cause of overprescribing? Br Med J (Clin Res Ed) (1986) 2.51

Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51

Senile dementia of the Alzheimer type. Ann Neurol (1983) 2.47

Breathing exercises for asthma: a randomised controlled trial. Thorax (2008) 2.46

Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice. BMJ (2000) 2.46

Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron (1995) 2.45

The meaning of cognitive impairment in the elderly. J Am Geriatr Soc (1985) 2.43

Alzheimer's disease. N Engl J Med (1986) 2.37

The private finance initiative: the politics of the private finance initiative and the new NHS. BMJ (1999) 2.21

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Assessing patient dependence in Alzheimer's disease. J Gerontol (1994) 2.16

Mobile phone technology in the management of asthma. J Telemed Telecare (2005) 2.15

Self-perceived health and 5-year mortality risks among the elderly in Shanghai, China. Am J Epidemiol (1998) 2.14

Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest (2000) 2.11

A simple constant-infusion manometric test for measurement of CSF absorption. I. Rationale and method. Neurology (1970) 2.11

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry (1990) 2.04

Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med (2001) 2.04

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature (1980) 2.02

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology (1998) 1.96

Women, myocardial infarction, and dementia in the very old. Neurology (1990) 1.94

Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol (1994) 1.90

A 40,000 year-old human occupation site at Huon Peninsula, Papua New Guinea. Nature (1987) 1.80

International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79

Neurobiology of autism. Ann Neurol (1998) 1.78

Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol (1987) 1.78

Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol (1973) 1.77

Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology (2002) 1.74

Spatial characterization of interictal high frequency oscillations in epileptic neocortex. Brain (2009) 1.73

Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem (1999) 1.72

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J (2005) 1.70

Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med (2012) 1.68

Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology (2000) 1.67

Positive and negative regulatory elements of the rabbit embryonic epsilon-globin gene revealed by an improved multiple alignment program and functional analysis. DNA Seq (1993) 1.66

Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell Biochem (1998) 1.66

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology (1996) 1.64

The plasmin system is induced by and degrades amyloid-beta aggregates. J Neurosci (2000) 1.62

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord (1993) 1.60

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology (1997) 1.58

Conduction aphasia. A clinicopathological study. Arch Neurol (1973) 1.57

Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57

Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann Neurol (1989) 1.55

Epidemiology of shingles. J R Soc Med (1990) 1.52

SF-36 scores vary by method of administration: implications for study design. J Public Health Med (1999) 1.51

Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev (1997) 1.49

Measurement of the W boson mass with the D0 detector. Phys Rev Lett (2012) 1.46

Education for general practitioners proposing to administer anaesthesia in rural general practice. Anaesth Intensive Care (1993) 1.43

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Neuroaxonal dystrophy in congenital biliary atresia. J Neuropathol Exp Neurol (1966) 1.41

Reduction of K+ uptake in glia prevents long-term depression maintenance and causes epileptiform activity. J Neurosci (1997) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Reorganizing the "organic" disorders. Hosp Community Psychiatry (1990) 1.39

An ethical dilemma: erectile dysfunction in the HIV-positive patient: to treat or not to treat. Int J STD AIDS (2002) 1.39

Cortical abnormalities in epilepsy revealed by local EEG synchrony. Neuroimage (2007) 1.37

Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn (1996) 1.36

Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy (2007) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Posttraumatic stress disorder in primary care. J Fam Pract (1999) 1.34

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study. J Urol (2007) 1.30

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol (1998) 1.30

Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thorax (2003) 1.29

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome. Ann Neurol (1982) 1.27

3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier. Life Sci (1975) 1.26

Understanding the potential role of mobile phone-based monitoring on asthma self-management: qualitative study. Clin Exp Allergy (2007) 1.26

Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Dis Assoc Disord (1993) 1.25

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24

Cross-cultural studies of dementia. A comparison of mini-mental state examination performance in Finland and China. Arch Neurol (1989) 1.23

Low-dose phenobarbitone as an indicator of compliance with drug therapy. Br J Clin Pharmacol (1987) 1.23

Cell death in age-related macular degeneration. Mol Vis (1999) 1.23

Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol (1994) 1.23

Clinical and neuropathological findings in Lewy body dementias. Brain Cogn (1996) 1.23

Report of Joint Committee for Stroke Resources. IV. Brain edema in stroke. Stroke (1977) 1.22

Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol (1995) 1.22

Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med (1977) 1.20

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19